Statistics for A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND)
Total visits
views | |
---|---|
A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND) | 43 |
Total visits per month
views | |
---|---|
December 2024 | 1 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
RESPOND_ArticleOphthalmicResearch_2017.pdf(legacy) | 186 |
MAJOR RIBEIRO FARIA.pdf(legacy) | 1 |
Dissertação Sília MLPO.pdf(legacy) | 1 |
RESPOND_ArticleOphthalmicResearch_2017.pdf | 1 |
Top country views
views | |
---|---|
United States | 19 |
Portugal | 8 |
China | 7 |
France | 1 |
United Kingdom | 1 |
Hong Kong SAR China | 1 |
Ireland | 1 |
India | 1 |
Mexico | 1 |
New Zealand | 1 |